Lana Gatserelia
YOU?
Author Swipe
View article: SARS-CoV-2 antibody seroprevalence in Tbilisi, the capital city of country of Georgia
SARS-CoV-2 antibody seroprevalence in Tbilisi, the capital city of country of Georgia Open
Background Georgia timely implemented effective response measures, with testing, contact tracing and isolation being the main pillar of the national response, achieving the lowest cumulative incidence of SARS-CoV-2 in the European region. …
View article: The natural history of recent hepatitis C virus infection among blood donors and injection drug users in the country of Georgia
The natural history of recent hepatitis C virus infection among blood donors and injection drug users in the country of Georgia Open
Additional studies are needed to define clinical and public health implications of transitory HCV viremia. Our study suggests the need for implementing nucleic acid testing of blood donors and key populations in order to more effectively i…
View article: Hospital-Based Surveillance for Infectious Etiologies Among Patients with Acute Febrile Illness in Georgia, 2008–2011
Hospital-Based Surveillance for Infectious Etiologies Among Patients with Acute Febrile Illness in Georgia, 2008–2011 Open
Information on the infectious causes of undifferentiated acute febrile illness (AFI) in Georgia is essential for effective treatment and prevention. In May 2008, a hospital-based AFI surveillance was initiated at six hospitals in Georgia. …
View article: World Hepatitis Day — July 28, 2015
World Hepatitis Day — July 28, 2015 Open
marks the fifth annual World Hepatitis Day, established in 2010 by the World Health Organization to increase awareness and understanding of viral hepatitis.Millions of acute hepatitis infections occur each year, and approximately 400 milli…
View article: High incidence of the hepatitis C virus recombinant 2k/1b in Georgia: Recommendations for testing and treatment
High incidence of the hepatitis C virus recombinant 2k/1b in Georgia: Recommendations for testing and treatment Open
Aim The first hepatitis C virus (HCV) recombinant, RF2k/1b, was initially described from Russia and has since then been identified from patients in Ireland, Estonia, Uzbekistan and Cyprus. Many of these patients originated from Georgia; ho…